{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T02:53:18Z","timestamp":1787712798640,"version":"build-2784847793"},"reference-count":52,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jpet.2025.103744","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:04:56Z","timestamp":1759939496000},"page":"103744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Essential roles of mechanistic target of rapamycin in the induction of steroid resistance in group 2 innate lymphoid cells and severe asthma"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6498-8335","authenticated-orcid":false,"given":"Masaya","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Shimora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misaki","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaha","family":"Kitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ariyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0812-7690","authenticated-orcid":false,"given":"Yuya","family":"Sannomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpet.2025.103744_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1677\/joe.0.1780347","article-title":"Corticosteroid-insensitive asthma: molecular mechanisms","volume":"178","author":"Adcock","year":"2003","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103744_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1152\/japplphysiol.00329.2007","article-title":"Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation","volume":"104","author":"Sorkness","year":"2008","journal-title":"J Appl Physiol (1985)"},{"issue":"5","key":"10.1016\/j.jpet.2025.103744_bib3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jpet.2025.103744_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaci.2017.12.1009","article-title":"Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids","volume":"143","author":"Peters","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103744_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1248\/bpb.b19-00095","article-title":"Steroid-resistant asthma and neutrophils","volume":"43","author":"Nabe","year":"2020","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.jpet.2025.103744_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70010","article-title":"Chronic inflammation in asthma: looking beyond the Th2 cell","volume":"330","author":"Olsthoorn","year":"2025","journal-title":"Immunol Rev"},{"issue":"5","key":"10.1016\/j.jpet.2025.103744_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1165\/rcmb.2016-0099OC","article-title":"IL-13+ type 2 innate lymphoid cells correlate with asthma control status and treatment response","volume":"55","author":"Jia","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"7","key":"10.1016\/j.jpet.2025.103744_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103744_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/imr.12706","article-title":"The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms","volume":"286","author":"Kabata","year":"2018","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.jpet.2025.103744_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaci.2017.03.032","article-title":"Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin","volume":"141","author":"Liu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jpet.2025.103744_bib11","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1038\/ncomms3675","article-title":"Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation","volume":"4","author":"Kabata","year":"2013","journal-title":"Nat Commun"},{"issue":"51","key":"10.1016\/j.jpet.2025.103744_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi3770","article-title":"JAK3 inhibitor suppresses multipotent ILC2s and attenuates steroid-resistant asthma","volume":"9","author":"Kim","year":"2023","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.jpet.2025.103744_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/imm.13805","article-title":"Involvement of Janus kinase-dependent Bcl-xL overexpression in steroid resistance of group 2 innate lymphoid cells in asthma","volume":"172","author":"Shimora","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.jpet.2025.103744_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/jimmun\/vkaf171","article-title":"Cyclin-dependent kinase (CDK) 8 and its paralog CDK19 develop group 2 innate lymphoid cell\u2013related lung fibrosis by activating signal transducer and activator of transcription (STAT) 5","author":"Matsuda","year":"2025","journal-title":"J Immunol"},{"key":"10.1016\/j.jpet.2025.103744_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174732","article-title":"Pathogenic changes in group 2 innate lymphoid cells (ILC2s) in a steroid-insensitive asthma model of mice","volume":"916","author":"Matsuda","year":"2022","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103744_bib16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"10.1016\/j.jpet.2025.103744_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.jpet.2025.103744_bib18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jaci.2012.05.018","article-title":"IL-33 induces innate lymphoid cell\u2013mediated airway inflammation by activating mammalian target of rapamycin","volume":"130","author":"Salmond","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jpet.2025.103744_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.915906","article-title":"Rapamycin dampens inflammatory properties of bone marrow ILC2s in IL-33-induced eosinophilic airway inflammation","volume":"13","author":"Boberg","year":"2022","journal-title":"Front Immunol"},{"issue":"18","key":"10.1016\/j.jpet.2025.103744_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.169736","article-title":"TRAF4 is crucial for ST2+ memory Th2 cell expansion in IL-33\u2013driven airway inflammation","volume":"8","author":"Xiao","year":"2023","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.jpet.2025.103744_bib21","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.4049\/jimmunol.1102133","article-title":"Rapamycin attenuates airway hyperreactivity, goblet cells, and IgE in experimental allergic asthma","volume":"187","author":"Mushaben","year":"2011","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jpet.2025.103744_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033984","article-title":"Paradoxical effects of rapamycin on experimental house dust mite-induced asthma","volume":"7","author":"Fredriksson","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jpet.2025.103744_bib23","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1042\/CS20150149","article-title":"Cellular and molecular effects of the mTOR inhibitor everolimus","volume":"129","author":"Saran","year":"2015","journal-title":"Clin Sci (Lond)"},{"issue":"25","key":"10.1016\/j.jpet.2025.103744_bib24","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2310793121","article-title":"Unconventional mechanism of action and resistance to rapalogs in renal cancer","volume":"121","author":"Yang","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.jpet.2025.103744_bib25","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1399-0012.2010.01370.x","article-title":"Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients","volume":"25","author":"Vallin","year":"2011","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.jpet.2025.103744_bib26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/TP.0000000000001392","article-title":"Wound healing complications in kidney transplant recipients receiving everolimus","volume":"101","author":"Ueno","year":"2017","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.jpet.2025.103744_bib27","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/leu.2008.204","article-title":"Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis","volume":"22","author":"Gu","year":"2008","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.jpet.2025.103744_bib28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/1078-0432.CCR-15-0114","article-title":"Modulation of glucocorticoid resistance in pediatric T-cell acute lymphoblastic leukemia by increasing BIM expression with the PI3K\/mTOR inhibitor BEZ235","volume":"22","author":"Hall","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.jpet.2025.103744_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1164\/rccm.201503-0593OC","article-title":"Restoration of corticosteroid sensitivity in chronic obstructive pulmonary disease by inhibition of mammalian target of rapamycin","volume":"193","author":"Mitani","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jpet.2025.103744_bib30","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1248\/bpb.b22-00480","article-title":"Rapamycin restores different patterns of cytokine expression to dexamethasone treatment on CD14++ CD16+ monocytes from steroid-resistant asthma patients","volume":"46","author":"Lee","year":"2023","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"10.1016\/j.jpet.2025.103744_bib31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mai.2002.122465","article-title":"p38 mitogen-activated protein kinase\u2013induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma","volume":"109","author":"Irusen","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.jpet.2025.103744_bib32","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/me.2002-0144","article-title":"Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation","volume":"16","author":"Itoh","year":"2002","journal-title":"Mol Endocrinol"},{"issue":"7","key":"10.1016\/j.jpet.2025.103744_bib33","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1210\/me.2006-0345","article-title":"Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress","volume":"21","author":"Kino","year":"2007","journal-title":"Mol Endocrinol"},{"issue":"12","key":"10.1016\/j.jpet.2025.103744_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027627","article-title":"Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma","volume":"6","author":"Kobayashi","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jpet.2025.103744_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041582","article-title":"Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma","volume":"7","author":"Mercado","year":"2012","journal-title":"PLOS One"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2025.103744_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0303-7207(01)00722-5","article-title":"The anti-inflammatory action of glucocorticoids is mediated by cell type specific regulation of apoptosis","volume":"189","author":"Amsterdam","year":"2002","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103744_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1189\/jlb.0903450","article-title":"On the link between Bcl-2 family proteins and glucocorticoid-induced apoptosis","volume":"76","author":"Almawi","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103744_bib38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1254\/jphs.11083FP","article-title":"Complete dependence on CD4+ cells in late asthmatic response, but limited contribution of the cells to airway remodeling in sensitized mice","volume":"116","author":"Nabe","year":"2011","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.jpet.2025.103744_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2011.12.020","article-title":"Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation","volume":"36","author":"Halim","year":"2012","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.jpet.2025.103744_bib40","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.1016\/S0021-9258(20)89482-4","article-title":"Identification of phosphorylated sites in the mouse glucocorticoid receptor","volume":"266","author":"Bodwell","year":"1991","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.jpet.2025.103744_bib41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/iub.245","article-title":"Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease","volume":"61","author":"Galliher-Beckley","year":"2009","journal-title":"IUBMB Life"},{"issue":"15","key":"10.1016\/j.jpet.2025.103744_bib42","doi-asserted-by":"crossref","first-page":"8393","DOI":"10.1093\/nar\/gkaa565","article-title":"Anti-inflammatory functions of the glucocorticoid receptor require DNA binding","volume":"48","author":"Escoter-Torres","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpet.2025.103744_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2017.06.037","article-title":"Regulation of allergic airway inflammation by adoptive transfer of CD4+ T cells preferentially producing IL-10","volume":"812","author":"Matsuda","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103744_bib44","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.jpet.2025.103744_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40169-020-0262-5","article-title":"PI3K inhibitor treatment ameliorates the glucocorticoid insensitivity of PBMCs in severe asthma","volume":"9","author":"Bi","year":"2020","journal-title":"Clin Transl Med"},{"issue":"5","key":"10.1016\/j.jpet.2025.103744_bib46","doi-asserted-by":"crossref","first-page":"C1172","DOI":"10.1152\/ajpcell.00504.2010","article-title":"ERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signaling","volume":"300","author":"Winter","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"10.1016\/j.jpet.2025.103744_bib47","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tcb.2015.06.002","article-title":"Regulation of mTORC1 by PI3K signaling","volume":"25","author":"Dibble","year":"2015","journal-title":"Trends Cell Biol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103744_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-016-0484-y","article-title":"Deptor: not only a mTOR inhibitor","volume":"36","author":"Catena","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.jpet.2025.103744_bib49","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/intimm\/9.7.945","article-title":"Elevated expression of Bcl-2 and Bcl-x by intestinal intraepithelial lymphocytes: resistance to apoptosis by glucocorticoids and irradiation","volume":"9","author":"Van Houten","year":"1997","journal-title":"Int Immunol"},{"issue":"7","key":"10.1016\/j.jpet.2025.103744_bib50","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.3390\/ijms23073795","article-title":"Overcoming steroid resistance in pediatric acute lymphoblastic leukemia-the state-of-the-art knowledge and future prospects","volume":"23","author":"Ko\u015bmider","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"16","key":"10.1016\/j.jpet.2025.103744_bib51","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1111\/bph.12749","article-title":"Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitations","volume":"171","author":"Moschetta","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103744_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exphem.2017.02.004","article-title":"Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia","volume":"50","author":"Ghosh","year":"2017","journal-title":"Exp Hematol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:13:05Z","timestamp":1773918785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525402572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0022356525402572"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103744","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Essential roles of mechanistic target of rapamycin in the induction of steroid resistance in group 2 innate lymphoid cells and severe asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103744"}}